Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (15)

2019

  1. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 46-54

2018

  1. Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): A pharmacogenetic-based randomized phase II trial

    Annals of Oncology, Vol. 29, Núm. 2, pp. 439-444

2017

  1. Prognostic significance of venous thromboembolic events in disseminated germ cell cancer patients

    Journal of the National Cancer Institute, Vol. 109, Núm. 4

2016

  1. Molecular characterization of HER2-positive (HER2+) metastatic gastric and gastro-esophageal junction cancer patients (mGC): Identification of resistance mechanisms to trastuzumab-based therapy (TTZ)

    Annals of Oncology, Vol. 27, pp. vi213

2014

  1. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

    Annals of Oncology, Vol. 25, Núm. 1, pp. 216-225

2013

  1. A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

    Annals of Oncology, Vol. 24, Núm. 7, pp. 1777-1785

  2. Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: A Spanish, multicentre, open-label, single arm phase II study

    BMC Cancer, Vol. 13

2011

  1. Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines

    Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 536-544

  2. SEOM clinical guidelines for diagnosis and treatment of testicular seminoma (2010)

    Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 560-564

2010

  1. SEOM clinical guidelines for the adjuvant treatment of colorectal cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 724-728

2009

  1. Diagnóstico y tratamiento del carcinoma hepatocelular

    Medicina Clinica, Vol. 132, Núm. 7, pp. 272-287

2005

  1. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5- fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study

    European Journal of Cancer, Vol. 41, Núm. 9, pp. 1254-1260

  2. Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer

    Clinical Colorectal Cancer, Vol. 4, Núm. 6, pp. 384-389

2001

  1. Clinical pattern and therapeutic results obtained in germ-cell testicular cancer in Spain based on a consecutive series of 1250 patients

    Medicina Clinica, Vol. 116, Núm. 13, pp. 481-486

1998

  1. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

    Annals of Oncology, Vol. 9, Núm. 7, pp. 727-731